The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
News|Webcasts|March 3, 2025
Microbial Testing: Ensuring Safety and Quality of Cannabis Ingredients Throughout the Supply Chain
Author(s)Medical Genomics
Listen
0:00 / 0:00
Webinar Date/Time: Thu, Mar 20, 2025 10:00 AM EDT
Hear from microbiologists and other experts to stay informed about the requirements and best practices for microbial testing of cannabis.
Register Free:
Event Overview:
Join this virtual symposium from Cannabis Science and Technology to stay informed on the requirements, best practices, as well as the latest techniques and methodologies related to microbial testing of cannabis. The symposium will contain valuable insights for a range of stakeholders, from lab technicians to product manufacturers, giving industry the tools to safeguard the integrity of the cannabis marketplace.
Key Learning Objectives:
- Understand the microbial testing requirements for cannabis to meet quality standards across state jurisdictions.
- Learn best practices for how to test for microbial contamination.
- Be updated on techniques and methodologies that ensure consistent and accurate testing for microbial contaminants.
Who Should Attend:
- Lab technicians
- QA/QC managers
- Cultivators
- Extraction Scientists
For any technical questions please contact Jorge de la Bandera: [email protected]
Full Event Agenda:
10:00 am EDT Laboratory Responses to Challenges of Their Test Results
Susan Audino, PhD, S.Audino & Associates LLC
10:30 am EDT Cannabis Microbiology Testing: Culture vs. Molecular Methods for Safety and Compliance
Anthony Repay, Laboratory Director, Method testing labs
Register Free:
Related to this article
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Our top cannabis news topics this week: President Trump’s executive order on cannabis rescheduling, hemp regulation legislation, NY program using cannabis to reduce opioid use, cannabis genetics and cannabinoid profiles, and the latest cannabis research studies.
This month’s webinar explored published research studies on cannabis and its effect on opioids, substance use reduction, alcohol use, and autism symptoms.
President Trump signed an executive order directing federal agencies to reclassify cannabis from Schedule I to Schedule III controlled substances.
A recent study found that medical cannabis may play a role in decreasing opioid use.
The review analyzed more than 2,500 articles, finding inconsistent evidence for certain conditions and an increased risk for harm.
Our top cannabis news topics this week: Texas medical cannabis, first Native American-owned East Coast cannabis brand, pivoting with hemp manufacturing, low-dose CBD and stress, and alcohol-induced liver disease.